TRPV1 function in health and disease

Current Pharmaceutical Biotechnology

Volumn 12, Issue 1, 2011, Pages 130-144

  White, John P M ^a   Urban, Laszlo ^b   Nagy, Istvan ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b Discovery Technologies   (United States)

Author keywords

Capsaicin; Central nervous system; Inflammation; Neuropathy; Pain; Peripheral nervous system; TRPV1; Vanilloid

Indexed keywords

ANANDAMIDE; CAPSAICIN; CAPSAZEPINE; LIPOPOLYSACCHARIDE; VANILLOID RECEPTOR 1;

AIRWAY; ARTICLE; AUDITORY SYSTEM; BURNING SENSATION; CARCINOGENESIS; CELL ACTIVITY; CELL PROTECTION; CHRONIC PANCREATITIS; DIABETES CONTROL; DIABETES MELLITUS; DIGESTIVE SYSTEM; ENDOTOXEMIA; HAIR GROWTH; HEADACHE; HEARING; HEAT; HEMORRHOID; HOMEOSTASIS; HUMAN; HYPERSENSITIVITY; INFLAMMATION; LUNG; METABOLIC DISORDER; METABOLISM; NEUROPATHIC PAIN; NONHUMAN; OBESITY; PAIN; PEPPER; PROSTATE CANCER; PROTEIN EXPRESSION; PRURITUS; RESPIRATORY SYSTEM; SKIN CELL; URINARY TRACT; VULVAR VESTIBULITIS; VULVODYNIA;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; ION CHANNEL GATING; NEOPLASMS; NOCICEPTORS; PRURITUS; TRPV CATION CHANNELS; URINARY TRACT;

CAPSICUM ANNUUM VAR. ANNUUM;

EID: 78650861447     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111793937844     Document Type: Article

References (184)

1. Guo, A.; Vulchanova, L.; Wang, J.; Li, X.; Elde, R. Immunocyto-chemical localisation of the vanilloid receptor (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur. J. Neurosci., 1999, 11, 946-958.
2. Pare, M.; Elde, R.; Mazurkiewicz, J.E.; Smith, A.M.; Rice, F.L. The Meissner corpuscle revised: a multiafferented mechanoreceptor with nociceptor immunochemical properties. J. Neurosci., 2001, 21, 7236-7246.
3. Nagy, I., Sensory processing: primary afferent neurons/DRG. In: Anesthetic Pharmacology: Physiologic Principles and Clinical Practice; Evers, A.S., Maze, M., Eds.; Churchill Livingstone: Philadelphia, 2004 pp. 187-189.
4. Caterina, M.J.; Schumacher, M.A.; Tominaga, M.; Rosen, T.A.; Levine, J.D.; Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 1997, 389, 816-824.
5. Ryu, S.; Liu, B.; Qin, F., Low pH potentiates both capsaicin binding and channel gating of VR1 receptors. J. Gen. Physiol., 2003, 122, 45-61.
6. Voets, T.; Droogmans, G.; Wissenbach, U.; Janssens, A.; Flockerzi, V.; Nilius B. The principle of temperature-dependent gating in cold-and heat-sensitive TRP channels. Nature, 2004, 430, 748-754.
7. Matta, J.A.; Ahern, G.P. Voltage is a partial activator of rat thermosensitive TRP channels. J. Physiol., 2007, 585, 469-482.
8. Tominaga, M.; Caterina, M.J.; Malmberg, A.B.; Rosen, T.A.; Gilbert, H.; Skinner, K.; Raumann, B.E.; Basbaum, A.I.; Julius, D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron, 1998. 21, 531-543.
9. Chuang, H.H.; Prescottt, E.D.; Kong, H.; Shields, S.; Jordt, S.E.; Basbaum, A.I.; Caho, M.V.; Julius, D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature, 2001, 411, 957-962.
10. Liang, Y.F.; Haake, B.; Reeh, P.W. Sustained sensitization and recruitment of rat cutaneous nociceptors by bradykinin and a novel theory of its excitatory action. J. Physiol. 2001, 523, 229-239.
11. Shin, J.; Cho, H.; Hwang, S.W.; Jung, J.; Shin, Cu.; Lee, S.Y.; Kim, S.H.; Lee, M.G.; Choi, Y.H.; Kim, J.; Haber, N.A.; Reichling, D.B.; Khasar, S.; Levine, J.D.; Oh, U. Bradykinin-12-lipoxygenase-VR1 signalling pathway for inflammatory hyperalegesia. Proc. Natl. Acad. Sci. USA, 2002, 99, 10150-10155.
12. Sugiura, T.; Tominaga, M.; Katsuya, H.; Mizumura, K. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J. Neurophysiol., 2002, 88, 544-548.
13. Morenilla-Palao, C.; Planells-Cases, R.; Garcia-Sanz, N.; FerrerMontiel, A. Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J. Biol. Chem., 2004, 79, 25665-25672.
14. Moriyama, T.; Higashi, T.; Togashi, K.; Iida, T.; Segi, E.; Sugimoto, Y.; Tominaga, T.; Narumiya, S.; Tominaga, M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. Mol. Pain, 2005, 1, 3.
15. Zhang, X.; Huang, J.; McNaughton, P.A. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J., 2005, 24, 4211-4223.
16. Stein, A.T.; Ufret-Vincenty, C.A.; Hua, L.; Santana, L.F.; Gordon, S.E., Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J. Gen. Physiol., 2006, 28, 509-522.
17. White, J.P.M.; Cibelli, M.; Rei Fidalgo, A.; Paule, C.C.; Noormohamed, F.; Urban, L.; Maze, M.; Nagy, I. Role of transient receptor potential and acid-sensing ion channels in peripheral inflammatory pain. Anesthesiology, 2010, 112, 729-741.
18. Olah, Z.; Szabo, T.; Karai, L.; Hough, C.; Fields, R.D.; Caudle, R.M.; Blumberg, P.M.; Iadarola, M.J., Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J. Biol. Chem., 2001, 276, 11021-11030.
19. Karai, L.J.; Russell, J.T.; Iadarola, M.J.; Olah, Z. Vanilloid receptor 1 regulates multiple calcium compartments and contributes to Ca++-induced Ca++ release in sensory neurons. J. Biol. Chem., 2004, 279, 16377-16387.
20. Jancso, G.; Kiraly, E.; Jancso-Gabor, A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature, 1977, 270, 741-743.
21. Vriens, J.; Janssens, A.; Prenen, J.; Nilius, B.; Wondergem, R. TRPV channels and modulation by hepatocyte growth factor/scatter factor in human hepatoblastoma (HepG2) cells. Cell Calcium, 2004, 36, 19-28.
22. Waning, J.; Vriens, J.; Owsianik, G.; Stuwe, L.; Mally, S.; Fabian, A.; Frippiat, C.; Nilius, B.; Schwab, A. A novel function of capsaicin-sensitive TRPV1 channels: Involvement in cell migration. Cell Calcium, 2006, 42, 17-25.
23. Urban, L.; White, J.P.M.; Nagy, I. Molecular structure of transient receptor potential vanilloid type 1 ion channel (TRPV1). Curr. Pharm. Biotech., 2010
24. Nagy, I.; White, J.P.M.; Paule, C.; Urban, L. Functional molecular biology of the transient receptor potential vanilloid type 1 (TRPV1) ion channel. Kofalvi, A., Ed.; In: Cannabinoids and the Brain; Springer: New York, 2008, pp. 101-130.
25. Nagy, I.; Paule, C.C.; White, J.P.M. Molecular Mechanisms of TRPV1-Mediated Pain. Jancso, G., Ed.; In: Neuroimmune Biology; Elsevier: Amsterdam, 2009, Vol. 8, pp. 75-99.
26. Nagy, I.; Santha, P.; Jancso, G.; Urban, L. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur. J. Pharmacol., 2004, 500, 351-369.
27. Szallasi, A.; Cortright, D.N.; Blum, C.A.; Eid, S.R. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat. Rev. Drug Discov., 2007, 6, 357-372.
28. Gunthorpe, M.J.; Szallasi, A. Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr. Pharm. Des., 2008, 14, 32-41.
29. Michael, G.J.; Priestley, J.V. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J. Neurosci., 1999, 19, 1844-1854.
30. Valtschanof, J.G.; Rustioni, A.; Guo, A.; Hwang, S.J. Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn. J. Comp. Neurol., 2001, 436, 225-235.
31. Kelly, S.; Chapman, V. Spinal administration of capsazepine inhibits noxious evoked responses of dorsal horn neurons in non-inflamed and carrageenan inflamed rats. Brain Res., 2002, 935, 103-108.
32. Ferrini, F.; Salio, C.; Vergnano, A.M.; Merighi, A. Vanilloid receptor-1 (TRPV1)-dependent activation of inhibitory neurotransmission in spinal substantia gelatinosa neurons of mouse. Pain, 2007, 129, 195-209.
33. Kim, H.; Cui, L.; Kim, J.; Kim, S.J. Transient receptor potential vanilloid type 1 receptor regulates glutamatergic synaptic inputs to the spinothalamic tract neurons of the spinal cord deep dorsal horn. Neuroscience, 2009, 160, 508-516.
34. Mezey, E.; Toth, Z.E.; Cortright, D.N.; Arzubi, M.K.; Krause, J.E.; Elde, R.; Guo, A.; Blumberg, P.M.; Szallasi, A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. USA, 2000, 97, 3655-3660.
35. Palazzo, E.; de Novellis, V.; Marabese, I.; Cuomo, D.; Rossi, F.; Berrino, L.; Maione, S., Interaction between vanilloid and glutamate receptors in the the central modulation of nociception. Eur. J. Pharmacol., 2002, 439, 69-75.
36. Xing, J.; Li, J. TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl_PAG) neurons. J. Neurophysiol., 2007, 97, 503-511.
37. Cui, M.; Honore, P.; Zhong, C.; Gauvin, D.; Mikusa, J.; Hernandez, G.; Chandran, P.; Gomtsyan, A.; Brown, B.; Bayburt, E.K.; Marsh, K.; Bianchi, B.; McDonald, H.; Niforatos, W.; Neelands, T.R.; Moreland, R.B.; Decker, M.W.; Lee, C.H.; Sullivan, J.P.; Faltynek, C.R. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J. Neurosci., 2006, 26, 9385-9393.
38. Maione, S.; Starowicz, K.; Cristino, L.; Guida, F.; Palazzo, E.; Luongo, L.; Rossi, F.; Marabese, I.; de Novellis, V.; Di Marzo, V. Functional interaction between TRPV1 and micro-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia. J. Neurophysiol., 2009, 101, 2411-2422.
39. Davis, J.B.; Gray, J.; Gunthorpe, M.J.; Hatcher, J.P.; Davey, P.T.; Overend, P.; Harries, M.H.; Latcham, J.; Clapham, C.; Atkinson, K.; Hughes, S.A.; Rance, K.; Grau, E.; Harper, A.J.; Pugh, P.L.; Rogers, D.C.; Bingham, S.; Randall, A.; Sheardown, S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature, 2000, 405, 183-187.
40. Caterina, M.J.; Leffler, A.; Malmberg, A.B.; Martin, W.J.; Trafteon, J.; Persen-Zeitz, K.R.; Koltzenburg, M.; Basbaum, A.I.; Julius, D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science, 2000, 288, 306-313.
41. Amaya, F.; Shimosato, G.; Nagano, M.; Ueda, M.; Hashimoto, S.; Tanaka, Y.; Suzuki, H.; Tanaka, M., NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia. Eur. J. Neurosci., 2004, 20, 2303-2310.
42. Chuang, H.H.; Prescott, E.D.; Kong, H.; Shields, S.; Jordt, S.E.; Basbaum, A.I.; Caho, M.V.; Julius, D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature, 2001, 411, 957-962.
43. Hudson, L.J.; Bevan, S.; Wotherspoon, G.; Gentry, C.; Fox, A.; Winter, J. VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur. J. Neurosci., 2001, 13, 2105-2114.
44. Kawamata, T.; Ji, W.; Yamamoto, J.; Niiyama, Y.; Furuse, S.; Namiki, A. Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia. Neuro-science, 2008, 154, 1067-1076.
45. Ro, J.Y.; Lee, J.S.; Zhang, Y. Activation of TRPV1 and TRPA1 leads to muscle nociception and mechanical hyperalgesia. Pain, 2009, 144, 270-277.
46. Ghilardi, J.R.; Rohrich, H.; Lindsay, T.H.; Sevcik, M.A.; Schwei, M.J.; Kubota, K.; Halvorson, K.G.; Poblete, J.; Chaplanm, S.R.; Dubin, A.E.; Carruthers, N.I.; Swanson, D.; Kuskowski, M.; Flores, C.M.; Julius, D.; Mantyh, P.W., Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J. Neurosci., 2005, 25, 3126-3131.
47. Zahner, M.R.; Li, D.P.; Chen, S.R.; Pan, H.L., Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J. Physiol., 2003, 551, 515-523.
48. Pan, H.L.; Cehn, S.R. Sensing tissue ischemia: Another new function for capsaicin receptors. Circulation, 2004, 110, 1826-1831.
49. Wu, Z.-Z.; Pan, H.-L. Role of TRPV1 and intracellular Ca++ in excitation of cardiac sensory neurons by bradykinin. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 293, R276-R283.
50. Barton, N.J.; McQueen, D.S.; Thomson, D.; Gauldie, S.D.; Wilson, A.W.; Salter, D.M.; Chessell, I.P. Attenuation of experimental arthritis in TRPV1R knockout mice. Exp. Mol. Pathol., 2006, 81, 166-170.
51. Fernihough, J.; Gentry, C.; Bevan, S.; Winter, J. Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci. Lett., 2005, 388, 75-80.
52. Russell, F.A.; Fernandes, E.S.; Courade, J.P.; Keeble, J.E.; Brain, S.D. Tumour necrosis factor mediates transient receptor potential vanilloid 1-dependent bilateral thermal hyperalgesia with distinct peripheral roles of interleukin-1, protein kinase C and cyclooxy-genase-2 signalling. Pain, 2009, 142, 264-274.
53. Iwanaga, T.; Shikichi, M.; Kitamura, H.; Yanase, H.; Nozawa-Inoue, K., Morphology and functional roles of synoviocytes in the joint. Arch. Histol. Cytol., 2000, 63, 17-31.
54. Kochukov, M.Y.; McNearney, T.A.; Fu, Y.; Westlund, K.N., Thermosenstive TRP ion channels mediate cytosolic calcium response in human synovicytes. Am. J. Physiol. Cell Physiol., 2006, 291, C432-C434.
55. Engler, A.; Aeschlimann, A.; Simmen, B.R.; Michel, B.A.; Gay, R.E.; Gay, S.; Sprott, H. Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthtritis. Biochem. Biophys. Res. Commun., 2007, 359, 884-888.
56. Hu, F.; Sun, W.W.; Zhao, X.T.; Cui, Z.J.; Yang, W.X. TRPV1 mediates cell death in rat synovial fibroblasts through calcium entry-dependent ROS production and mitochondrial depolarization. Biochem. Biophys. Res. Commun., 2008, 369, 989-993.
57. Helyes, Z.; Sandor, K.; Borbely, E.; Tekus, V.; Pinter, E.; Elekes, K.; Toth, D.M.; Szolcsanyi, J.; McDougall, J.J. Involvement of transient receptor potential vanilloid 1 receptors in proteaseactivated receptor-2-induced joint inflammation and nociception. Eur. J. Pain., 2010, 14(4), 351-358.
58. Pabbidi, R.M.; Yu, S.-Q.; Peng, S.; Khardori, R.; Pauza, M.E.; Premkumar, L.S. Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity. Mol. Pain, 2008, 4, 9.
59. Fukuoka, T.; Tokunaga, A.; Tachibana, T.; Dai, Y.; Yamanaka, H.; Noguchi, K. VR1, but not P2X3, increases in the spared L4 DRG in rats with L5 spinal nerve ligation. Pain, 2002, 99, 111-120.
60. Kanai, Y.; Nakazato, E.; Jujiuchi, A.; Hara, T.; Imai, A. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology, 2005, 49, 977-984.
61. Huang, S.J.; Valtschanoff, S.G. Vanilloid receptor VR1-positive afferents are distributed differently at different levels of the rat lumbar spinal cord. Neurosci. Lett., 2003, 349, 41-44.
62. Walker, K.; Urban, L.; Medhurst, S.J.; Patel, S.; Panesar, M.; Fox, A.J.; McIntyre, P., The VR1 antagonist, capsazepine, reverses hyperalgesia in models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther., 2003, 304, 56-62.
63. Christoph, T.; Gillen, C.; Mika, J.; Grunweller, A.; Schater, M.K.H.; Schiene, K.; Frank, R.; Jostock, R.; Bahrenberg, G.; Weihe, E.; Erdmann, V.A.; Kurreck, J. Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1. Neurochem. Int., 2007, 50, 281-290.
64. Vass, Z.; Dai, C.F.; Steyger, P.S.; Jancso, G.; Trune, D.R.; Nuttall, A.L. Co-localization of the vanilloid capsaicin receptor and substance P in sensory nerve fibres innervating cochlear and vertebro-basilar arteries. Neuroscience, 2004, 124, 919-927.
65. Akerman, S.; Kaube, H.; Goadsby, P.J. Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br. J. Pharmacol., 2004, 142, 1354-1360.
66. Goadsby, P.J. Emerging therapies for migraine. Nat. Clin. Pract. Neurol., 2007, 3, 610-619.
67. Tympanidis, P.; Casulam, M.A.; Yiangoum, Y.; Terenghim, G.; Dowdm, P.; Anand, P. Increased vanilloid receptor VR1 innervation in volvodynia. Eur. J. Pain, 2004, 8, 129-133.
68. Steinberg, A.C.; Oyama, I.A.; Rejba, A.E.; Kellogg-Spadt, S.; Whitmore, K.E. Capsaicin for the treatment of vulvar vestibulitis. Am. J. Obstet. Gynecol., 2005, 192, 1549-1553.
69. Shim, W.S.; Tak, M.H.; Lee, M.H.; Kim, M.; Kim, M.; Koo, J.Y.; Lee, C.H.; Kim, M.; Oh, U. TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J. Neurosci., 2007, 27, 2331-2337.
70. Alenmyr, L.; Hogestatt, E.D.; Zygmunt, P.M.; Greiff, L. TRPV1-mediated itch in seasonal allergic rhinitis. Allergy, 2009, 64, 807-810.
71. Zhu, Y.; Wang, Y.; Wang, D.H. Diuresis and natriuresis caused by activation of VR1-positive sensory nerves in renal pelvis of rats. Hypertension, 2005, 6, 992-997.
72. Zhu, Y.; Xie, C.; Wang, D.H., TRPV1-mediated diuresis and natriuresis induced by hypertonic saline perfusion of the renal pelvis. Am. J. Nephrol., 2007, 27, 530-537.
73. Zhu, Y.; Wang, D.H., TRPV1-mediated diuresis and natriuresis induced by hypertonic saline perfusion of the renal pelvis. J. Cardiovasc. Pharmacol., 2008, 51, 437-442.
74. Xie, C.; Sachs, J.R.; Wang, D.H., Inter-dependent regulation of afferent renal nerve activity and renal function: Role of TRPV1, NK1 and CGRP receptors. J. Pharm. Exp. Ther., 2008, 325, 751-757.
75. Li, J.; Wang, D.H., Increased GFR and renal excretory function by activation of TRPV1 in the isolated perfused kidney. Pharmacol. Res., 2008, 57, 239-246.
76. Jancso-Gabor, A.; Szolecsanyi, J.; Jancso, N., Stimulation and de-sensitization of the hypothalamic heat-sensitive structure by capsaicin in rats. J. Physiol., 1970, 208, 444-459.
77. Gavva, N.R.; Treanor, J.J.; Garami, A.; Fang, L.; Surapaneni, S.; Akrami, A.; Alvarez, F.; Bak, A.; Darling, M.; Gore, A.; Jang, G.R.; Kesslak, J.P.; Ni, L.; Norman, M.H.; Palluconi, G.; Rose, M.J.; Salfi, M.; Tan, E.; Romanovsky, A.A.; Banfield, C.; Davar, G. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain, 2008, 136, 202-210.
78. Masamoto, Y.; Kawabata, F.; Fushiki, T. Intragastric administration of TRPV1, TRPV3, TRPM8, and TRPA1 agonists modulates autonomic thermoregulation in different manners in mice. Biosci. Biotechnol. Biochem., 2009, 73, 1021-1027.
79. Gavva, N.R.; Bannon, A.W.; Surapaneni, S.; Hovland, D.N.; Lehto, S.G.; Gore, A.; Juan, T.; Deng, H.; Han, B.; Klionsky, L.; Kuang, R.; Le, A.; Tamir, R.; Wang, J.; Youngblood, B.; Zhu, D.; Norman, M.H.; Magal, E.; Treanor, J.J.; Louis, J.C., The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J. Neurosci., 2007, 27, 3366-33674.
80. Romanovsky, A.A.; Almeida, M.C.; Garami, A.; Steiner, A.A.; Norman, M.H.; Morrison, S.F.; Nakamura, K.; Burmeister, J.J.; Nucci, T.B. The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol. Rev., 2009, 61, 228-261.
81. Ayoub, S.S.; Hunter, J.C.; Simmons, D.L. Answering the burning question of how transient receptor potential vanilloid-1 channel antagonists cause unwanted hyperthermia. Pharmacol. Rev., 2009, 61, 225-227.
82. Sharif-Naeini, R.; Ciura, S.; Bourque, C.W. TRPV1 gene required for thermosensory transduction and anticipatory secretion from vasopressin neurons during hyperthermia. Neuron, 2008, 58, 179-185.
83. Wang, S.; Davis, B.M.; Zwick, M.; Waxman, S.G.; Albers, K.M. Reduced termal sensitivy and Nav1.8 and TRPV1 channel expression in sensory neurons of aged mice. Neurobiol. Aging, 2006, 27, 895-903.
84. Scotland, R.S.; Chauhan, S.; Davis, C.; De Felipe, C.; Hunt, S.; Kabir, J.; Kotsonis, P.; Oh, U.; Ahluwalia, A., Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: A novel mechanism involved in myogenic constriction. Circ. Res., 2004, 95, 1027-1034.
85. Kark, T.; Bagi, Z.; Lizanecz, E.; Pasztor, E.T.; Erdei, N.; Czikora, A.; Papp, Z.; Edes, I.; Porszasz, R.; Toth, A. Tissue specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1 (TRPV1). Mol. Pharm., 2008, 73, 1405-1412.
86. Wang, Y.; Wang, D.H. A novel mechanism contributing to development of Dahl salt-sensitive hypertension. Role of the transient receptor potential vanilloid type 1. Hypertension, 2006, 47, 609-614.
87. Ciura, S.; Bourque, C.W., Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J. Neurosci., 2006, 26, 9069-9075.
88. Taylor, A.C.; McCarthy, J.J.; Stocker, S.D. Mice lacking the transient receptor vanilloid potential 1 channel display normal thirst responses and central Fos activation to hypernatremia. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2008, 294, R1285-R1293.
89. Liu, L.; Che, L.; Liedtke, W.; Simon, S.A. Changes in osmolality sensitise the response to capsaicin in trigeminal sensory neurons. J. Neurophysiol., 2007, 97, 2001-2015.
90. Sexton, A.; McDonald, M.; Cayla, C.; Thiemermann, C.; Ahluwalia, A. 12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1. FASEB J., 2007, 21, 2695-2703.
91. Wang, L.; Wang, D.H. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice Circulation, 2005, 112, 3617-3623.
92. Huang, W.; Rubinstein, J.; Prieto, A.R.; Wang, D.H., Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction. J. Hypertens., 2009, 53, 243-250.
93. Goswami, C.; Dreger, M.; Otto, H.; Schwappach, B.; Hucho, F. Rapid disassembly of dynamic microtubules upon activation of the capsaicin receptor TRPV1. J. Neurochem., 2006, 96, 254-266.
94. Goswami, C.; Schmidt, H.; Hucho, F. TRPV1 at nerve endings regulates growth cone morphology and movement through cytoskeleton reorganization. FEBS J., 2007, 274, 760-772.
95. Shin, C.Y.; Shin, J.; Kim, B.-M.; Wang, M.-H.; Jange, J.-H.; Surh, Y.-J.; Oh, U. Essential role of mitochondrial permeability transition in vanilloid receptor 1-dependent cell death of sensory neurons. Mol. Cell. Neurosci., 2003, 24, 57-58.
96. Athanasiou, A.; Smith, P.A.; Vakilpour, S.; Kumaran, N.M.; Turner, A.E.; Bagiokou, D.; Layfield, R.; Ray, D.E.; Westwell, A.D.; Alexander, S.P.H.; Dendall, D.A.; Lobo, D.N.; Watson, S.A.; Lophatanon, A.; Muir, K.A.; Guo, D.; Bates, T.E., Vanilloid receptor agonists and atagonists are mitochondrial inhibitors: How vanilloids cause non-vanilloid receptor mediated cell death. Biochem. Biophys. Res. Commun., 2007, 354, 50-55.
97. Amantini, C.; Mosca, M.; Lucciarini, R.; Perfumi, M.; Morrone, S.; Piccoli, M.; Santonim, G. Distinct thymocyte subsets express the vanilloid receptor VR1 that mediates capsaicin-induced apoptotic cell death. Cell Death Differ., 2004, 11, 1342-1356.
98. Maccarrone, M.; Lorenzon, T.; Bari, M.; Melino, G.; Finazzi-Agro, A. Anandamide induces apoptosis in human cells via vanilloid receptors. J. Biol. Chem., 2000, 275, 31938-31945.
99. Jabrina, E.; Alonso, R.; Alcalde, M.; del Carmen Rodriguez, M.; Serrrano, A.; Martinez, A.C.; Garcia-Sancho, J.; Izquierdo, M. B. Calcium influx through receptor-operated channel induces mitochondria-triggered paraptotic cell death. Biol. Chem., 2003, 278, 14134-14145.
100. Kim, S.R.; Lee, D.Y.; Chung, E.S.; Oh, U.T.; Kim, S.U.; Jin, B.K., Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. J. Neurosci., 2005, 25, 662-671.
101. Kim, S.R.; Kim, S.U.; Oh, U.; Jin, B.K. Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca++-mediated mitochondrial damage and cytochrome c release. J. Immunol., 2006, 177, 432-439.
102. Varga, K.; Wagner, J.A.; Bridgen, D.T.; Kunos, G. Plateletand macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J., 1998, 12, 1035-1044.
103. Orliac, M.L.; Peroni, R.; Celuch, S.M.; Adler-Graschinsky, E. Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats. J. Pharmacol. Exp. Ther., 2003, 304, 179-184.
104. Orliac, M.L.; Peroni, R.N.; Abramoff, T.; Neuman, I.; Podesta, E.J.; Adler-Graschinsky, E. Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats. Eur. J. Pharmacol., 2007, 566, 145-152.
105. Iida, T.; Shimizu, I.; Nealen, M.L.; Campbell, A.; Caterina, M. Attenuated fever response in mice lacking TRPV1. Neurosci. Lett., 2005, 378, 28-33.
106. Wang, Y.; Novotny, M.; Quaiserova-Mocko, V.; Swain, G.M.; Wang, D.H., TRPV1-mediated protection against endotoxin-induced hypotension and mortality in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2008, 294, R1517-R1523.
107. Matthews, P.J.; Aziz, Q.; Facer, P.; Davis, J.B.; Thompson, D.G.; Anand, P. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur. J. Gastroenterol. Hepatol., 2004, 16, 897-902.
108. Boudaka, A.; Worl, J.; Shina, T.; Saito, S.; Atoji, Y.; Kobayashi, H.; Shimizu, Y.; Takewaki, T. Key role of mucosal primary afferents in mediating the inhibitory influence of capsaicin on vagally mediated contractions in the mouse esophagus. J. Vet. Med. Sci., 2007, 69, 365-372.
109. Cheng, L.; de la Monte, S.; Ma, J.; Hong, J.; Tong, M.; Cao, W.; Behar, J.; Biancani, P.; Harnett, K.M., HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 297, G135-G143.
110. Geppetti, P.; Trevisani, M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br. J. Pharmacol., 2004, 141, 1313-1320.
111. Ward, S.M.; Bayguinov, J.; Won, K.-J.; Grundy, D.; Berthoud, H.R. Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract. J. Comp. Neurol., 2003, 465, 121-135.
112. Patterson, L.M.; Zheng, H.; Ward, S.M.; Berthoud, H.-R. Vanilloid receptor (V1) expression in vagal afferent neurons innervating the gastrointestinal tract. Cell Tissue Res., 2003, 311, 277-287.
113. Rong, W.; Hillsley, K.; Davis, J.B.; Hicks, G.; Winchester, W.J.; Grundy, D. Jejunal afferent nerve sensitivity in wild-type and TRPV1 knockout mice. J. Physiol., 2004, 560, 867-881.
114. Yiangou, Y.; Facem, P.; Dyerm, N.H.C.; Chanm, C.L.H.; Knowles, C.; Williamsm, N.S.; Anand, P. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet, 2001, 357, 1338-1339.
115. Akbar, A.; Yiangou, Y.; Facer, P.; Walters, J.R.F.; Anand, P.; Ghosh, S. Increased capsaicin receptor TRPV1 expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut, 2008, 57, 923-929.
116. Winston, J.; Shenoy, M.; Medley, D.; Naniwadekar, A.; Pasricha, P.J. The vanilloid receptor initiates and maintains colonic hyper-sensitivity induced by neonatal colon irritation in rats. Gastroenterology, 2007, 132, 615-637.
117. Ravenfjord, A.; Brusberg, M.; Kang, D.; Bauer, U.; Larsson, H.; Lindstrom, E.; Martinez, V. Involvement of the transient receptor potential vanilloid 1 (TRPV1) in the development of acute visceral hyperalgesia during colorectal distension in rats. Eur. J. Pharmacol., 2009, 611, 85-91.
118. Spencer, N.J.; Kerrin, A.; Singer, C.A.; Hennig, G.W.; Gerthoffer, W.T.; McDonnell, O. Identification of capsaicin-sensitive rectal mechanoreceptors activated by rectal distension in mice. Neuroscience, 2008, 153, 518-534.
119. Miranda, A.; Nordstrom, E.; Mannem, A.; Smith, C.; Banerjee, B.; Sengupta, J.N. The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis. The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis. Neuroscience, 2007, 148, 1021-1032.
120. De Schepper, H.U.; De Man, J.G.; Ruyssers, N.E.; Deiteren, A.; Van Nassauw, L.; Timmermans, J.-P.; Martinet, W.; Herman, A.G.; Pelckmans, P.A.; De Winter, B.Y. TRPV1 receptor signalling mediates afferent nerve sensitization during colitis-induced motility disorders in rats. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 294, G245-G253.
121. Matsumoto, K.; Kurosawa, E.; Terui, H.; Hosoya, T.; Tashima, K.; Murayama, T.; Priestley, J.V.; Horie, S. Localization of TRPV1 and contractile effect of capsaicin in mouse large intestine: high abundance and sensitivity in rectum and distal colon. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 297, G348-G360.
122. De Winter, B.Y.; Bredenoord, A.J.; Van Nassauw, L.; De Man, J.G.; De Schepper, H. U.; Timmermans, J.P.; Pelckmans, P.A. Involvement of afferent neurons in the pathogenesis of endotoxin-induced ileus in mice: role of CGRP and TRPV1 receptors. Eur. J. Pharmacol., 2009, 615, 177-184.
123. Di Mola, F.F.; Friessm, H.; Koningerm, J.; Selvaggi, F.; Exposito, I.; Buchler, M.W.; di Sebastiano, P. Haemorrhoids and transient receptor potential vanilloid 1. Gut, 2006, 55, 1665-1666.
124. Santha, P.; Nagy I. Insulin-induced membrane currents in capsaicin-sensitive primary sensory neurons. J. Physiol., 2004, 565P, C117.
125. Sathianathan, V.; Avelino, A.; Charrua, A.; Santha, P.; Matesz, K.; Cruz, F.; Nagy, I. Insulin induces cobalt uptake in a subpopulation of rat cultured primary sensory neurons. Eur. J. Neurosci., 2003, 18, 2477-2486.
126. Razavi, R.; Chanm Y.; Afifiyanm, F.N.; Liu, X.J.; Wan, X.; Yantha, J.; Tsui, H.; Tang, L.; Tsai, S.; Santamaria, P.; Driver, J.P.; Serreze, D.; Salter, M.W.; Dosch H.M. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell, 2006, 127, 1123-1135.
127. Gram, D.X.; Ahren, B.; Nagy, I.; Olsen, U.B.; Brand, C.L.; Sundler, F.; Tabanera, R.; Svendsen, O.; Carr, R.D.; Santha, P.; Wierup, N.; Hansen, A.J. Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes. Eur. J. Neurosci., 2007, 25, 213-223.
128. Kozlova, E.N.; Jansson, L., In vitro interactions between insulin-producing beta cells and embryonic dorsal root ganglia. Pancreas, 2005, 31, 380-384.
129. Sopasakis, V.R.; Nagaev, I.; Smith, U. Cytokine release from adipose tissue of non-obese individuals. Int. J. Obes. Lond., 2005, 29, 1144-1147.
130. Grady, E.F.; Yoshim, S.K.; Maa, J.; Valeroso, D.; Vartanian, R.K.; Rahim, S.; Kim, E.H.; Gerard, C.; Bunnet, N.W.; Kirkwood, K.S., Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br. J. Pharmacol., 2000, 130, 505-512.
131. Nathan, J.D.; Patel, A.A.; McVey, D.C.; Thomas, J.E.; Prpic, V.; Vigna, S.R.; Liddle, R.A. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol., 2001, 281, G1322-G1328.
132. Hutter, M.M.; Wick, E.C.; Day, A.L.; Maa, J.; Zerega, E.C.; Richmond, A.C.; Jordan, T.H.; Grady, E.F.; Mulvihill, S.J.; Bunnett, N.W.; Kirkwood, K.S. Transient receptor potential vanilloid (TRPV-1) promotes neurogenic inflammation in the pancreas via activation of the neurokinin-1 receptor (NK-1R). Pancreas, 2005, 30, 260-265.
133. Wick, E.C.; Hoge, S.G.; Grahn, S.W.; Kim, E.; Divino, L.A.; Grady, E.F.; Bunnet, N.W.; Kirkwood, K.S., Transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P mediate nociception in acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 290, G959-G969.
134. Zhang, L.L.; Yan Liu, D.; Ma, L.Q.; Luo, Z.D.; Cao, T.B.; Zhong, J.; Yan, Z.C.; Wang, L.J.; Zhao, Z.G.; Zhu, S.J.; Schrader, M.; Thilo, F.; Zhu, Z.M.; Tepel, M. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ. Res., 2007, 100, 1063-1070.
135. Wang, X.; Miyares, R.L.; Ahern, G.P., Oleoylethanolamide excites vagal sensory neurons, induces visceral pain and reduces shortterm food intake in mice via capsaicin receptor TRPV1. J. Physiol., 2005, 564, 541-547.
136. Avelino, A.; Cruz, F. TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. Naunyn-Schmiedeberg's Arch. Pharmacol., 2006, 373, 287-299.
137. Charrua, A.; Cruz, C.D.; Cruz, F.; Avelino, A., Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J. Urol., 2007, 177, 1537-1541.
138. Charrua, A.; Reguenga, C.; Cordeiro, J.M.; Correiade-Sa, P.; Paule, C.; Nagy, I.; Cruz, F.; Avelino A. Functional transient receptor potential vanilloid 1 is expressed in human urothelial cells. J. Urol., 2009, 182, 2944-2950.
139. Seki, N.; Shirasaki, H.; Kikuchi, M.; Sakamato, T.; Watanabe, N.; Himi, T. Expression and localization of TRPV1 in human nasal mucosa. Rhinology, 2006, 44, 128-134.
140. Watanabe, N.; Horie, S.; Michael, G.J.; Spina, D.; Page, C.P.; Priestley, J.V. Immunohistochemical localization of vanilloid receptor subtype 1 (TRPV1) in the guinea pig respiratory system. Pulm. Pharmacol. Ther., 2005, 18, 187-197.
141. Watanabe, N.; Horie, S.; Michael, G.J.; Keir, S.; Spina, D.; Page, C.P.; Priestley, J.V. Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV) 1 and sensory neuropeptides in the guinea-pig respiratory system. Neuroscience, 2006, 141, 1533-1543.
142. Kichko, T.I.; Reeh, P.W., TRPV1 controls acid-and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea. Eur. J. Neurosci., 2009, 29, 1896-1904.
143. Zhang, G.; Lin, R.L.; Wiggers, M.; Snow, D.M.; Lee, L.Y. Altered expression of TRPV1 and sensitivity to capsaicin in pulmonary myelinated afferents following chronic airway inflammation in the rat. J. Physiol., 2008, 586, 5771-5786.
144. Hamamoto, T.; Takumida, M.; Hirakawa, K.; Tatsukawa, T.; Ishibashi, T. Localization of transient receptor potential vanilloid (TRPV) in the human larynx. Acta Otolaryngol., 2009, 129, 560-568.
145. Bessac, B.F.; Jordt, S.-E. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda), 2008, 23, 360-370.
146. Agopyan, N.; Bhatti, T.; Yu, S.; Simon, S.A. Vanilloid receptor activation by 2-and 10-microm particles induces responses leading to apoptosis in human airway epithelial cells. Toxicol. Appl. Pharmacol., 2003, 192, 21-35.
147. Agopyan, N.; Head, J.; Yu, S.; Simon, S.A. TRPV1 receptors mediate particulate matter-induced apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol., 2004, 286, L563-L572.
148. Reilly, C.A.; Taylor, J.L.; Lanza, D.L.; Carr, B.A.; Crouch, D.J.; Yost, G.S., Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors. Toxicol. Sci., 2003, 73, 170-181.
149. Seki, N.; Shirasakai, H.; Kikuchi, M.; Himi, T. Expression and localization of TRPV1 in human nasal mucosa. Life Sci., 2007, 80, 1592-1597.
150. Blom, H.M.; Van Ruswijk, J.B.; Garrelds, I.M.; Mulder, P.G.; Timmermans, T.; Gerth van Wijk, R. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. Clin. Exp. Allergy, 1997, 27, 796-801.
151. Van Rijswijk, J.B.; Boeke, E.L.; Keizer, J.M.; Mulder, P.G.H.; Blom, H.M.; Fokkens, W.J. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study. Allergy, 2003, 58, 754-761.
152. Groneberg, D.A.; Niimi, A.; Thai Dinh, Q.; Cosio, B.; Hew, M.; Fischer, A.; Chung, K.F. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am. J. Respir. Crit. Care Med., 2004, 170, 1276-1280.
153. McLeod, R.L.; Fernandez, X.; Correll, G.C.; Phelps, T.P.; Jia, Y.; Wang, X.; Hey, J.A. TRPV1 antagonists attenuate antigen-provoked cough in ovalbumin sensitized guinea pigs. Cough, 2006, 2, 10.
154. Jia, Y.; McLeod, R.L.; Wang, X.; Parra, L.E.; Egan, R.W.; Hey, J.A. Anandamide induces cough in conscious guinea pigs through VR1 receptors. Br. J. Pharmacol., 2002, 137, 831-836.
155. McLeod, R.L.; Jia, Y.; McHugh, N.A.; Fernandez, X.; Mingo, G.G.; Wang, X.; Parra, L.E.; Chen, J.; Brown, D.; Bolser, D.C.; Kreutner, W.; Hey, J.A., Sulfur-dioxide exposure increases TRPV1-mediated responses in nodose ganglia cells and augments cough in guinea pigs. Pulm. Pharmacol. Ther., 2007, 20, 750-757.
156. El-Hashim, A.Z.; Jaffal, S.M. Nerve growth factor enhances cough and airway obstruction via TrkA receptor-and TRPV1-dependent mechanisms. Thorax, 2009, 64, 791-797.
157. Thomas, K.C.; Sabnism A.S.; Johansenm M.E.; Lanza, D.L.; Moos, P.J.; Yost, G.S.; Reilly, C.A. Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells. J. Pharmacol. Exp. Ther., 2001, 321, 830-838.
158. Johansen, M.E.; Reilly, C.A.; Yost, G.S. TRPV1 antagonists elevate cell surface populations of receptor protein and exacerbate TRPV1-mediated toxicities in human lung epithelial cells. Toxicol. Sci., 2006, 89, 278-286.
159. Zheng, J.; Dai, C.; Steyger, P.S.; Kim, Y.; Vass, Z.; Ren, T.; Nuttal, A.L. Vanilloid receptors in hearing: altered cochlear sensitivity by vanilloids and expression of TRPV1 in organ of corti. J. Neurophysiol., 2003, 90, 444-455.
160. Takumida, M.; Kubo, N.; Ohtani, M.; Suzuka, Y.; Anniko, M. Transient receptor potential channels in the inner ear: presence of transient receptor potential channel subfamily 1 and 4 in the guinea pig inner ear. Acta Otolaryngol., 2005, 125, 929-934.
161. Kitahara, T.; Li, H.-S.; Balaban, C.D. Changes in transient receptor potential cation channel superfamily V (TRPV) mRNA expression in the mouse inner ear ganglia after kanamycin challenge. Hearing Res., 2005, 201, 132-144.
162. Zhou, J.; Balaban, C.; Durrant, J.D. Effect of intracochlear perfusion of vanilloids on cochlear neural activity in the guinea pig. Hearing Res., 2006, 218, 43-49.
163. Denda, M.; Fuziwara, S.; Inoue, K.; Denda, S.; Akamatsu, H.; Tomitaka, A.; Matunaga, K. Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem. Biophys. Res. Commun., 2001, 285, 1250-1252.
164. Stander, S.; Moormann, C.; Schumarcher, M.; Buddenkotte, J.; Artuc, M.; Shpacovitch, V.; Brzoska, T.; Lippert, U.; Henz, B.M.; Luger, T.A.; Metze, D.; Steinhoff, M. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp. Dermatol., 2004, 13, 129-139.
165. Pentland, A.P.; Needleman, P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J. Clin. Invest., 1986, 77, 246-251.
166. Travers, J.B.; Harrison, K.A.; Johnson, C.A.; Clay, K.L.; Morelli, J.G. Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes. J. Investig. Dermatol., 1996, 107, 88-94.
167. Alappatt, C.; Johnson, C.A.; Clay, K.L.; Travers, J.B. Acute keratinocyte damage stimulates platelet-activating factor production. Arch. Dermatol. Res., 2000, 292, 256-259.
168. Southall, M.D.; Li, T.; Gharibova, L.S.; Pei, Y.; Nicol, G.D.; Travers, J.B. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J. Pharmacol. Exp. Ther., 2003, 304, 217-222.
169. Fisher, G.J.; Kang, S.; Varani, J.; Bata-Csorgo, Z.; Wan, Y.; Datta, S. Mechanisms of photoaging and chronological skin aging. Arch. Dermatol., 2002, 138, 1462-1470.
170. Li, W.H.; Lee, Y.M.; Kim, J.Y.; Kang, S.; Kim, S.; Kim, K.H.; Park, C.-H.; Chung, J.H. Transient receptor potential vanilloid-1 mediates heat-shock-induced matrix metalloproteinase-1 expression in human epidermal keratinocytes. J. Invest. Dermatol., 2007, 127, 2328-2335.
171. Bodo, E.; Biro, T.; Telek, A.; Czifra, G.; Griger, Z.; Toth, B.I.; Mescalchin, A.; Ito, T.; Bettermann, A.; Kovács, L.; Paus, R. A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am. J. Pathol., 2005, 166, 985-998.
172. Zhang, F.; Yang, H.; Wang, Z.; Mergler, S.; Liu, H.; Kawakita, T.; Tachado, S.D.; Pan, Z.; Capo-Aponte, J.E.; Pleyer, U.; Koziel, H.; Kao, W.W.Y.; Reinach, P.S. Transient receptor potential vanilloid 1 activation induces inflammatory cytokine release in corneal epithelium thorough MAPK signalling. J. Cell Physiol., 2007, 213, 730-739.
173. Amantini, C.; Mosca, M.; Nabissi, M.; Lucciarini, R.; Captrodossi, S.; Arcella, A.; Giangaspero, F.; Santoni, G. Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J. Neurochem., 2007, 102, 977-990.
174. Lazzeri, M.; Vannucchi, M.G.; Spinelli, M.; Bizzoco, E.; Beneforti, P.; Turini, D.; Faussone-Pellegrini, M.-S. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. Eur. Urol., 2005, 48, 691-698.
175. Marincsak, R.; Toth, B.I.; Czifra, G.; Marton, I.; Redl, P.; Tar, I.; Toth, L.; Kovacs, L.; Biro, T. Increased expression of TRPV1 in squamous cell carcinoma of the human tongue. Oral Dis., 2009, 15, 328-335.
176. Czifra, G.; Varga, A.; Nyeste, K.; Marincsak, R.; Toth, B.I.; Kovacs, I.; Kovacs, L.; Biro, T. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J. Cancer Res. Clin. Oncol., 2009, 135, 507-514.
177. Mori, A.; Lehamann, S.; O'Kelly, J.; Kumagai, T.; Desmond, J.C.; Pervan, M.; McBride, W.H.; Kizaki, M.; Koeffler, H.P. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res., 2006, 66, 3222-3229.
178. Athanasiou, A.; Smith, P.A.; Vakilpour, S.; Kumaran, N.M.; Turner, A.E.; Bagiokou, D.; Layfield, R.; Ray, D.E.; Westwell, A.D.; Aleantder, S.P.H.; Dendall, D.A.; Lobo, D.N.; Watson, S.A.; Lophatannon, A.; Muir, K.A.; Guo, D.; Bates, T.E. Vanilloid receptor agonists and atagonists are mitochondrial inhibitors: How vanilloids cause non-vanilloid receptor mediated cell death, Biochem. Biophys. Res. Comm., 2007, 354, 50-55.
179. Hartel, M.; di Mola, F.F.; Selvaggi, F.; Mascetta, G.; Wente, M.N.; Felix, K.; Giese, N.A.; Hinz, U.; Di Sebastiano, P.; Buchler, M.W.; Friess, H. Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut, 2006, 55, 519-528.
180. Marsch, R.; Foeller, E.; Rammes, G.; Bunck, M.; Kossl, M.; Holsboer, F.; Zieglgansberger, W.; Landgraf, R.; Lutz, B.; Wotjak, C.T., Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J. Neurosci., 2007, 27, 832-839.
181. Li, H.B.; Mao, R.R.; Zhang, J.C.; Yang, Y.; Cao, J.; Xu, L. Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol. Psychiatry, 2008, 64, 862-892.
182. Gibson, H.E.; Edwards, J.G.; Page, R.S.; Van Hook, M.J.; Kauer, J.A. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron, 2008, 57, 746-759.
183. Kym, P.R.; Kort, M.E.; Hutchins, C.W. Analgesic potential of TRPV1 antagonists. Biochem. Pharmacol., 2009, 78, 211-216.
184. Holzer, P. The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br. J. Pharmacol., 2008, 155, 1145-1162.